A large, prospective, population-based cohort study in China (N = 567,071 couples) observed that folic acid supplementation started three months prior to conception may reduce the risk of NTDs (OR = 0.55, CI: 0.39-0.82, p=0.003) and clefts (OR = 0.59, 95% CI: 0.36-0.95, p=0.029 (54)
Read ordering, packaging, and delivery feedback
Higher dosing (3-5mg daily) Some protocols call for higher doses, particularly for acute wound healing, significant tissue repair, or when combining injectable with topical applications
Conclusion BPC-157 demonstrates therapeutic potential across a broad range of musculoskeletal injuries through its angiogenic, anti-inflammatory, cytoprotective, and tissue-regenerative properties